305 related articles for article (PubMed ID: 36244414)
1. Traumatic axonopathy in spinal tracts after impact acceleration head injury: Ultrastructural observations and evidence of SARM1-dependent axonal degeneration.
Alexandris AS; Lee Y; Lehar M; Alam Z; Samineni P; Tripathi SJ; Ryu J; Koliatsos VE
Exp Neurol; 2023 Jan; 359():114252. PubMed ID: 36244414
[TBL] [Abstract][Full Text] [Related]
2. Traumatic Axonal Injury in the Optic Nerve: The Selective Role of SARM1 in the Evolution of Distal Axonopathy.
Alexandris AS; Lee Y; Lehar M; Alam Z; McKenney J; Perdomo D; Ryu J; Welsbie D; Zack DJ; Koliatsos VE
J Neurotrauma; 2023 Aug; 40(15-16):1743-1761. PubMed ID: 36680758
[TBL] [Abstract][Full Text] [Related]
3. Primary Traumatic Axonopathy in Mice Subjected to Impact Acceleration: A Reappraisal of Pathology and Mechanisms with High-Resolution Anatomical Methods.
Ziogas NK; Koliatsos VE
J Neurosci; 2018 Apr; 38(16):4031-4047. PubMed ID: 29567804
[TBL] [Abstract][Full Text] [Related]
4. Sarm1 deletion reduces axon damage, demyelination, and white matter atrophy after experimental traumatic brain injury.
Marion CM; McDaniel DP; Armstrong RC
Exp Neurol; 2019 Nov; 321():113040. PubMed ID: 31445042
[TBL] [Abstract][Full Text] [Related]
5. Genetic inactivation of SARM1 axon degeneration pathway improves outcome trajectory after experimental traumatic brain injury based on pathological, radiological, and functional measures.
Bradshaw DV; Knutsen AK; Korotcov A; Sullivan GM; Radomski KL; Dardzinski BJ; Zi X; McDaniel DP; Armstrong RC
Acta Neuropathol Commun; 2021 May; 9(1):89. PubMed ID: 34001261
[TBL] [Abstract][Full Text] [Related]
6. Sarm1 loss reduces axonal damage and improves cognitive outcome after repetitive mild closed head injury.
Maynard ME; Redell JB; Zhao J; Hood KN; Vita SM; Kobori N; Dash PK
Exp Neurol; 2020 May; 327():113207. PubMed ID: 31962129
[TBL] [Abstract][Full Text] [Related]
7. Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1.
Henninger N; Bouley J; Sikoglu EM; An J; Moore CM; King JA; Bowser R; Freeman MR; Brown RH
Brain; 2016 Apr; 139(Pt 4):1094-105. PubMed ID: 26912636
[TBL] [Abstract][Full Text] [Related]
8. Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss.
White MA; Lin Z; Kim E; Henstridge CM; Pena Altamira E; Hunt CK; Burchill E; Callaghan I; Loreto A; Brown-Wright H; Mead R; Simmons C; Cash D; Coleman MP; Sreedharan J
Acta Neuropathol Commun; 2019 Oct; 7(1):166. PubMed ID: 31661035
[TBL] [Abstract][Full Text] [Related]
9. Myelin and oligodendrocyte lineage cells in white matter pathology and plasticity after traumatic brain injury.
Armstrong RC; Mierzwa AJ; Sullivan GM; Sanchez MA
Neuropharmacology; 2016 Nov; 110(Pt B):654-659. PubMed ID: 25963414
[TBL] [Abstract][Full Text] [Related]
10. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.
Geisler S; Doan RA; Strickland A; Huang X; Milbrandt J; DiAntonio A
Brain; 2016 Dec; 139(Pt 12):3092-3108. PubMed ID: 27797810
[TBL] [Abstract][Full Text] [Related]
11. White matter involvement after TBI: Clues to axon and myelin repair capacity.
Armstrong RC; Mierzwa AJ; Marion CM; Sullivan GM
Exp Neurol; 2016 Jan; 275 Pt 3():328-333. PubMed ID: 25697845
[TBL] [Abstract][Full Text] [Related]
12. Wallerian degeneration as a therapeutic target in traumatic brain injury.
Koliatsos VE; Alexandris AS
Curr Opin Neurol; 2019 Dec; 32(6):786-795. PubMed ID: 31633494
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy.
Bosanac T; Hughes RO; Engber T; Devraj R; Brearley A; Danker K; Young K; Kopatz J; Hermann M; Berthemy A; Boyce S; Bentley J; Krauss R
Brain; 2021 Nov; 144(10):3226-3238. PubMed ID: 33964142
[TBL] [Abstract][Full Text] [Related]
14. Sarm1 knockout protects against early but not late axonal degeneration in experimental allergic encephalomyelitis.
Viar K; Njoku D; Secor McVoy J; Oh U
PLoS One; 2020; 15(6):e0235110. PubMed ID: 32584865
[TBL] [Abstract][Full Text] [Related]
15. Components of myelin damage and repair in the progression of white matter pathology after mild traumatic brain injury.
Mierzwa AJ; Marion CM; Sullivan GM; McDaniel DP; Armstrong RC
J Neuropathol Exp Neurol; 2015 Mar; 74(3):218-32. PubMed ID: 25668562
[TBL] [Abstract][Full Text] [Related]
16. Traumatic axonal injury in the spinal cord evoked by traumatic brain injury.
Czeiter E; Pal J; Kovesdi E; Bukovics P; Luckl J; Doczi T; Buki A
J Neurotrauma; 2008 Mar; 25(3):205-13. PubMed ID: 18352834
[TBL] [Abstract][Full Text] [Related]
17. Experimental Traumatic Brain Injury Identifies Distinct Early and Late Phase Axonal Conduction Deficits of White Matter Pathophysiology, and Reveals Intervening Recovery.
Marion CM; Radomski KL; Cramer NP; Galdzicki Z; Armstrong RC
J Neurosci; 2018 Oct; 38(41):8723-8736. PubMed ID: 30143572
[TBL] [Abstract][Full Text] [Related]
18. SARM1-mediated wallerian degeneration: A possible mechanism underlying organophosphorus-induced delayed neuropathy.
Song M; Kang K; Song F
Med Hypotheses; 2021 Oct; 155():110666. PubMed ID: 34455132
[TBL] [Abstract][Full Text] [Related]
19. Sarm1 Deletion, but Not Wld
Gilley J; Ribchester RR; Coleman MP
Cell Rep; 2017 Oct; 21(1):10-16. PubMed ID: 28978465
[TBL] [Abstract][Full Text] [Related]
20. SARM1 can be a potential therapeutic target for spinal cord injury.
Lu Q; Botchway BOA; Zhang Y; Jin T; Liu X
Cell Mol Life Sci; 2022 Feb; 79(3):161. PubMed ID: 35224705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
